Man Group plc - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 163 filers reported holding PDL BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Man Group plc ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2019$132,000
+6.5%
35,600
-16.6%
0.00%0.0%
Q4 2018$124,000
-48.8%
42,700
-53.6%
0.00%0.0%
Q3 2018$242,000
-15.1%
92,100
-24.3%
0.00%0.0%
Q2 2018$285,000
-91.1%
121,600
-88.9%
0.00%
-93.3%
Q1 2018$3,215,000–1,093,640–0.02%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders